Conducting clinical research studies with
SKILL, KNOWLEDGE and SAFETY.
Call to participate
860.443.4567

Posts Tagged ‘ CCRstudies birth control ’

Nationwide Birth Control Study

Tuesday, August 22nd, 2017

Evofem Biosciences, Inc., a biotechnology company focused on the development and commercialization of women’s health products, announced the enrollment of the first patient in a Phase 3 clinical trial evaluating AMPHORA for the prevention of pregnancy.  Coastal Connecticut Research was selected by Evofem Biosciences as research site for the study. Dr. Robert M. Spitz is serving as the Primary Investigator in the study which is being conducted throughout the United States.  Research nurses include Kelley Sanok RN, Jeannine Elliott RN and Diane Palmer RN.

AMPHORA is an investigational compound being studied as a vaginal contraceptive and for the prevention of certain vaginal infections.  The local study is focusing on pregnancy prevention.  Women ages 18-35 throughout the country are participating in the study.

Coastal Connecticut Research has conducted a number of research trials pertaining to women’s healthcare and is announcing upcoming studies on stress urinary incontinence, hot flashes, and decreased sexual desire.

Those interested in learning more can contact the site at (860) 443-4567 or visit www.CCRstudies.com.  Coastal Connecticut Research is located on Montauk Avenue in New London, CT.